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Antimicrobial drug resistance is a global challenge for the 21st century with the emergence of resistant 
bacterial strains worldwide. Transferable resistance to β-lactam antimicrobial drugs, mediated by 
production of extended-spectrum β-lactamases (ESBLs), is of particular concern. In 2004, an ESBL-
carrying IncK plasmid (pCT) was isolated from cattle in the United Kingdom. The sequence was a 93,629-
bp plasmid encoding a single antimicrobial drug resistance gene, blaCTX-M-14. From this information, PCRs 
identifying novel features of pCT were designed and applied to isolates from several countries, showing 
that the plasmid has disseminated worldwide in bacteria from humans and animals. Complete DNA 
sequences can be used as a platform to develop rapid epidemiologic tools to identify and trace the 
spread of plasmids in clinically relevant pathogens, thus facilitating a better understanding of their 
distribution and ability to transfer between bacteria of humans and animals. 
Bacterial plasmids are key vectors of horizontal gene transfer, mediating the mobilization 
of genetic material from 1 bacterium to another. Their ability to capture DNA and to spread 
within and between bacterial species by conjugation facilitates the rapid dissemination of 
potentially beneficial genes through a bacterial population. These genes might alter virulence of 
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the host, confer metabolic benefits, or enable the bacteria to colonize new environments (1). 
Genes that confer resistance to antimicrobial drugs used in human or veterinary medicine are 
often mobilized on plasmids. One class of resistance genes encode extended-spectrum β-
lactamases (ESBLs), which confer resistance against many β-lactam antimicrobial drugs, leading 
to treatment failures (2). Within the past decade, cefotaximase-modifying (CTX-M) β-lactamases 
(CTX-M) have become the most prevalent ESBLs in bacteria isolated throughout the world in 
hospital and community settings (3). More than 85 variants have been identified 
(www.lahey.org/Studies), mainly in isolates of Escherichia coli that cause community-acquired 
urinary tract infections (4). Although clonal expansion events appear to have contributed to the 
spread of particular CTX-M variants, such as blaCTX-M-15 within E. coli strain O25:H4-ST131:05 
(5,6), plasmids with the ability to spread efficiently, or epidemic plasmids, also are believed to 
be responsible for disseminating CTX-M ESBLs (7). The ability and frequency with which 
antimicrobial resistance genes disseminate between bacteria in humans, the environment, and 
animals is still debated, and the role of plasmids in this movement between ecosystems, 
including the food chain, is also still contested, despite mounting evidence that it occurs (8,9). 
CTX-M-14 is the second most frequently identified CTX-M enzyme worldwide (10), 
detected in bacteria isolated from humans, animals, and the environment. CTX-M-14–producing 
strains show a high level of clonal diversity (11,12); therefore, dissemination has been attributed 
to conjugative plasmids rather than to clonal expansion of a bacterial host strain (13). In Europe, 
an association has been suggested between blaCTX-M-14 and plasmids of the incompatibility group 
IncK, or the spread of 1 particular IncK plasmid (11,13,14). In the United Kingdom in 2006, 
Liebana et al. described an ESBL-producing isolate from calves with diarrhea that carried  
blaCTX-M-14 on an IncK plasmid, denoted pCT (15,16). The plasmid spread to unrelated E. coli 
isolates within an index cattle farm and persisted within the environment. In this study, we report 
the full sequence and analysis of pCT and demonstrate the spread of pCT-like plasmids in animal 
and human E. coli isolates from the United Kingdom, Europe, Australia, and Asia. 
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Materials and Methods 
Bacterial Strains 
E. coli C159/11 was isolated from calves on a dairy farm in the United Kingdom in  
2004 (15,16). Investigation and manipulation of the C159/11 plasmid (pCT) was conducted  
in an E. coli DH5α transformant created for the current study. We also investigated 15  
CTX-M-14–producing E. coli isolates collected during 2006–2009 from cattle feces on farms  
in different geographic locations in the United Kingdom and 15 E. coli clinical isolates from 
England (P. Hawley, unpub. data), Germany (17), Spain (11,18), the People’s Republic of China 
(19), and Australia (20) (Table 1). 
Plasmid Extraction and Manipulation 
Plasmid pCT was extracted from E. coli DH5α transconjugants by using an alkaline 
sodium dodecyl sulfate Maxi preparation (21) and cesium chloride density gradient 
centrifugation (22). Conjugation was by solid mating on a filter (Whatman, Maidstone, UK), by 
using rifampin-resistant E. coli (DH5α) as a recipient and selection of transconjugants on Luria-
Bertani agar containing 50 µg/mL rifampin and 8 µg/mL cefotaxime. 
Antimicrobial Drug Susceptibility Testing 
Susceptibility of C159/11 and pCT transconjugants to a panel of antimicrobial drugs 
(ampicillin, cefotaxime, cefoxitin, chloramphenicol, ciprofloxacin, naladixic acid, streptomycin, 
and tetracycline) was determined by using a microtiter broth double dilution method 
(www.bsac.org.uk/_db/_documents/Chapter_2_Determination_of_MICs_2006.pdf). 
Susceptibility of E. coli DH5α to the antimicrobial drugs tested was also determined. 
Complete Mucleotide Sequencing of pCT 
The plasmid DNA sequence was determined by using a 454/Roche GS FLX analyzer 
(Roche, Basel, Switzerland). The de novo assembly generated 93631 bases in 7 contigs by using 
the 454/Roche Newbler assembly program with an N50 of 52,495 bp. The sequence represents 
improved high-quality draft sequence (23) with no discernable misassembles having undergone 
multiple rounds of computational gap closure. Annotation was completed by using Artemis 
(Sanger, Cambridge, UK). Further comparative analysis of the DNA sequence used Double ACT 
and Artemis Comparison Tool (Sanger, Cambridge, UK), DNAstar (Lasergene; Madison, WI, 
USA) and BLAST (www.ncbi.nlm.nih.gov/guide). 
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PCR Amplification and Sequencing 
Boiled bacterial cell lysates provided template DNA, 1 µL of which was added to PCR 
ReddyMix Master mixture (Abgene, Epson, UK). Typically, PCR conditions were 30 cycles of 
95°C for 30 sec, 51°C for 30 sec, and 72°C for 30 sec. PCR was used to detect blaCTX-M-14 and 
insertion sequences ISEcp1 and IS903 as described (24–26). All primers used are shown in Table 
2. To determine whether the pCT blaCTX-M-14 shares a common insertion site with blaCTX-M-14 on 
other plasmids, PCRs were designed to amplify the sequence from blaCTX-M-14 into both pCT 
flanking genes. 
Using the pCT sequence, we designed primer pairs to amplify novel regions of pCT for 
rapid identification of potential pCT-like plasmids in CTX-M-14–producing bacteria (Table 2). 
PCRs to amplify DNA encoding the putative sigma factor, pilN gene, and shufflon recombinase 
were developed into a multiplex PCR. An additional primer pair was designed to a unique region 
of pCT and compared with other known sequences for amplification across coding sequences 
(CDSs) pCT008–pCT009 for further discrimination of pCT-like plasmids. Sequencing of the 
relaxase gene has been reported to further categorize plasmids within the IncI complex (11,28). 
A modified primer pair was designed for this region (nikB) by using sequence data from pCT and 
other related sequenced plasmids. Resulting amplicons were sequenced by using BigDye 
Terminator version 3.1 cycle sequencing (Applied Biosystems, Foster City, CA, USA) at the 
functional genomics laboratory of the University of Birmingham (Birmingham, UK) sequences 
were aligned by using MEGA 4.0 (29) for phylogenetic analysis (30). Primers amplifying group 
9 blaCTX-M genes were used as a positive control in each instance. The complete DNA sequence 
of plasmid pCT was assigned GenBank accession no. F868832. 
Results 
Features of pCT 
The blaCTX-M-14–carrying plasmid isolated from E. coli C159/11 was demonstrated to be 
conjugative by successful transfer to E. coli DH5α by using filter mating and previously 
determined to be of the incompatibility group IncK (16). Analysis of transconjugants showed 
resistance to β-lactam antimicrobial drugs as the only transferrable resistance phenotype. Whole-
plasmid sequencing showed that pCT was 93,629 bp (Figure 1) with an average G+C content of 
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52.67%. Annotation of the plasmid showed 115 potential protein CDSs, 89 of which were 
homologous to proteins of known function (Technical Appendix, 
www.cdc.gov/EID/17/4/pdfs/10-1009-Techapp.pdf). No genes known to play a role in 
determining virulence were identified, and sequencing confirmed blaCTX-M-14 as the only 
antimicrobial drug resistance gene on pCT. The pCT blaCTX-M-14 gene is found between insertion 
sequences ISEcp1 and IS903 as described (31). 
Most of the identified putative coding open reading frames are typical for an IncK 
plasmid backbone (32). Two conjugal transfer systems were identified. The first is the more 
commonly described tra operon, which encodes the primary pilus for conjugation transfer. The 
pCT tra locus is analogous to the tra operon of R64/ColIb-P9 and is found in a similar 
conformation, although minor differences existed between the 3 plasmids throughout. The 
second is the pil locus encoding a thin pilus, which is believed to increase conjugation rates in 
liquid media. The tip of this thin pilus is variable, and the exact nature of the expressed epitope is 
determined by the orientation and order of pilV shufflon components (pCT_094-pCT_098), 
which can be inverted by the action of the recombinase protein (pCT_093) encoded downstream. 
Analysis of the pCT plasmid assembly showed that this region was present in multiple forms 
(data not shown), which is consistent with site-specific recombination mediated by a shufflon 
recombinase. The pCT shufflon potentially differs from that of the other closely related plasmids 
(pO113, pO26_vir and pSERB1) because each of these apparently has an inactive shufflon, 
which can be attributed to the absence of the recombinase or an insertion element within this 
CDS. The antirestriction and segregation genes on pCT are typical of this type of plasmid. 
Comparison of pCT with Other Plasmids 
When we compared complete sequences deposited in GenBank of plasmids carrying 
blaCTX-M genes with pCT, we found that outside the blaCTX-M gene those plasmids with different 
replication mechanisms, such as those within the IncFII group or of the IncN group (pKP96) 
(33), have almost no DNA homology to pCT. The only other blaCTX-M carrying IncI complex 
plasmid to be sequenced and deposited in GenBank thus far is a blaCTX-M-3 carrying IncI plasmid 
pEK204 (EU935740) (32). pEK204 shares sequence conservation over ≈60% of the pCT 
genome, including most of the core IncI complex–related genes for replication or transfer. 
Further similarities were found in the minimal carriage of resistance genes (Figure 2, panel D). 
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The pCT genome was also compared with other IncI group sequenced plasmids to 
identify regions considered core or backbone and to determine novel encoded genes. IncI 
complex reference plasmids R64 (AP005147) and ColIb-P9 (AB021078) shared 99% identity 
with 64% of the pCT sequence primarily within genes involved in replication and conjugation 
(Figure 2, panel C). Other plasmids compared with pCT included R387, the Sanger IncK 
reference plasmid, which shared a high percentage identity to pCT across IncK-specific core 
genes (Figure 2, panel B). 
We investigated novel genes by identifying regions of the pCT sequence absent from 
those plasmid sequences with most homology to pCT: pO26_vir (FJ38659), pO113 (AY258503), 
and the partially sequenced pSERB1 (AY686591), none of which carry blaCTX-M genes. Both 
pO26_vir (168,100 bp) and pO113 (165,548 bp) are large plasmids that carry several virulence 
genes and share 99% homology with 85% and 83% of the pCT genome, respectively (online 
Technical Appendix Table; Figure 2, panel A). pSERB1 also has high DNA sequence identity 
(91% of the pSERB1 deposited genome sequence has 99% identity to two thirds of the pCT 
sequence), however, because this plasmid is deposited in GenBank only as a partial sequence, 
the total identity cannot be assessed. 
Detection of pCT-like Plasmids in Animal and Human Isolates 
Fifteen CTX-M-14–producing E. coli isolates collected from different cattle farms 
around the United Kingdom were examined for pCT-like plasmids with a series of PCRs that 
amplified characteristic regions of pCT. Veterinary isolates I779 and I780 were obtained 2 years 
apart and from different geographic areas in the United Kingdom. These isolates carried 
plasmids encoding all 6 pCT regions that were investigated (blaCTX-M-14, nikB, putative sigma 
factor, rci, pilN, and pCT008–009) and when compared with pCT had identical flanking  
regions adjacent to blaCTX-M-14. Therefore, these plasmids were deemed pCT-like. Fifteen  
CTX-M-14–producing E. coli human clinical isolates from England, Germany (17), Spain 
(11,18), Australia (20), and China (19) also were examined for pCT (Table 1). No pCT-like 
plasmids were detected in the isolates from the United Kingdom and Germany. However,  
pCT-like plasmids were identified in 4 of 5 clinical isolates from Spain (C559; C567; C574; 
FEC383), 3 of 6 isolates from Australia (JIE 052, JIE 182, JIE 201), and the isolate from China 
(E. coli 8, CH13) because all sequences specific to pCT could be amplified by PCR. pCT-like 
plasmids have also been shown to be present in other clinical E. coli isolates from the United 
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Kingdom by using the same multiplex assay (M. Stokes et al., pers. comm.). Sequencing of 
amplicons generated during PCR amplification of nikB showed pCT-like plasmids had nikB 
sequences with >98% DNA identity to the pCT nikB sequence and clustered when these 
sequences were used to construct a phylogenetic tree (Figure 3). nikB sequences from  
non–pCT-like plasmids clustered further from pCT within the phylogenetic tree (Figure 3). This 
analysis further supports the hypothesis that pCT has disseminated broadly between bacteria in 
animal and human ecosystems. 
Discussion 
We report the complete sequence of a blaCTX-M-14–carrying IncK plasmid, pCT, from an 
E. coli isolate from a cattle farm in the United Kingdom (16). Within the 115 putative CDs, there 
is an absence of any genes known to play a role in determining virulence of the host and the 
absence of any other antimicrobial drug resistance genes except for blaCTX-M-14. Therefore, the 
persistence and spread of pCT cannot be attributed to coselection associated with pressure from 
non–β-lactam antimicrobial drugs. This finding suggests that pCT persistence and dissemination 
have been driven by either constant β-lactam exposure or that pCT can remain stable within a 
population in the absence of any antimicrobial drug selective pressure. There has been much 
speculation about the role of the type IV pilus and its shufflon found in plasmids and possible 
role(s) in adhesion of the host bacterium to surfaces and eukaryotic epithelial cells in vitro and in 
biofilm formation (34). The thin pilus might also aid conjugation in a liquid environment by 
anchoring donor and recipient cells (35). This system may have played a role in the persistence 
of E. coli C159/11, which originally was found to remain within slurry and on the floor of cow 
sheds during the longitudinal farm study from which it was identified (16). These attributes of 
the type IV pilus might contribute to the persistence of pCT within bacteria isolated from the UK 
farm and in animals and humans throughout the world. 
Two other features of pCT are of interest. The first, and most notable, is a putative RNA 
polymerase sigma factor (CDS pCT_066) within the sequence, which shares homology with 
genes found in only 4 closely related plasmids (pO26vir; pO113, TP113, and pSERB1) and has 
limited identity to homologue SigB in Yersinia frederiksenii. Other weak protein matches show 
some homology to the extracytoplasmic function sigma factors, small regulatory proteins 
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divergent in sequence to most of the other sigma factors and involved in global gene regulation. 
Both examples are chromosomally encoded. Although sigma factors of this group have 
previously been noted on plasmids, scant information has been published about their role or 
function. 
The second feature of interest is that in large stably maintained conjugative plasmids, 
such as R64, functional large addiction operons such as ParA/B or kor/mck usually are present; 
however, these are lacking in pCT. Despite the apparent lack of stability or persistence genes, 
pCT has remained stable in a population in the absence of selective pressure for prolonged 
periods (N.G. Coldham et al., unpub. data). 
Comparison of the genome of pCT with other blaCTX-M–encoding plasmids showed no 
conserved regions outside the β-lactamase gene. Therefore, no single feature of the plasmid 
backbone appears responsible for the spread of blaCTX-M genes, and the acquisition of these genes 
is unlikely to have been a single event. Homology was highest between pCT and 4 plasmids 
(pO26_vir, pO113, pSERB1, and TP113). pO26_vir was identified in a Shiga toxin–producing 
E. coli strain 026:HII and encodes several virulence genes not found on pCT, including genes for 
the production of a hydrolase, catalase, and a hemolysin transport protein. pO113 was isolated 
from another hemolysin-producing EHEC O113:H21 E. coli sample from a patient in Australia 
(36). The finding that pCT is most closely related to 2 plasmids that carry an array of virulence 
genes is of concern because of the potential for recombination between these plasmids, creating 
mobile elements carrying virulence genes and the blaCTX-M-14. 
The genome sequencing of pCT enabled development of PCRs that amplified discrete 
regions of the pCT sequence, thereby enabling rapid identification of other pCT-like plasmids 
that share these loci. pCT-like plasmids were identified in bacteria isolated from 2 other UK 
farms in 2006 and 2008 and, most recently, from human clinical isolates in the United Kingdom 
(M. Stokes et al., pers. comm.). 
Four human clinical isolates from Spain also carried pCT-like plasmids, with all 6 pCT 
regions amplified by PCR, which had the same insertion sites for blaCTX-M-14. These data show 
the ability of a large conjugative plasmid to transfer between bacteria isolated from humans and 
animals, facilitating the movement of blaCTX-M-14 between these niches. Since 2000, when  
CTX-M-14 was identified in bacteria from Spain, it has become one of the most commonly 
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detected enzymes isolated from human and animal isolates in Spain (24,37). Previous studies 
conducted in hospitals in Spain examined an association between blaCTX-M-14 and IncK plasmids. 
Valverde et al. (11) isolated an IncK plasmid, pRYC105, from many lineages of E. coli from 
community-acquired infections and the environment in different geographic regions of Spain. 
These authors hypothesized that pRYC105 shared identity with the plasmid isolated in the 
United Kingdom by Liebana et al. (16), and the present study has confirmed this hypothesis by 
showing that pRYC105 is pCT-like. 
Human clinical isolate E. coli 8 CH13, described in 2002 and isolated in 1998 from 
China, contained pOZ174, which encodes blaCTX-M-14 (19); as with pRYC105, we showed that 
pOZ174 is pCT like. Furthermore, our data suggest that pCT has persisted since 1998 and is 
distributed across Europe, Asia, and Australia in diverse E. coli lineages isolated from humans 
and animals. Because CTX-M-14 is the most frequently identified ESBL in Spain and China, 
further investigation using this molecular test will determine whether pCT is the dominant vector 
of blaCTX-M-14 in these areas and whether pCT has disseminated to other ecosystems. The 
identical insertion site for blaCTX-M-14 in each of the pCT-like plasmids investigated in our study 
suggests a single capture of this β-lactamase gene onto the plasmid backbone and subsequent 
spread of the plasmid. 
The alignment and analysis of nikB from pCT-like plasmids were also used to determine 
how related the plasmids are and demonstrated sequence identity of >98%. These sequences 
clustered with pCT within a phylogenetic tree, which indicated less sequence divergence than 
with other IncI complex non–pCT-like plasmids. Design of the pCT–specific PCRs distributed 
throughout the plasmid and sequencing of nikB amplicons provided a useful and rapid tool in 
first identifying pCT-like plasmids. Relaxase or nikB typing also would provide a suitable locus 
in recently developed plasmid multilocus sequence typing. These assays can now be used to 
screen CTX-M-14–producing bacteria for other pCT-like plasmids. 
The sequence of pCT enabled an understanding of its backbone and seems to suggest 
that, apart from plasmid replication and transfer functions, the only known gene that confers a 
selective advantage on this plasmid is blaCTX-M-14. Subsequent PCRs successfully indicated that 
pCT-like plasmids are distributed over several countries worldwide in bacteria isolated from 
humans and animals. This approach can be applied to the study of other plasmids of clinical 
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relevance and facilitate better trace analyses of horizontally acquired antimicrobial drug 
resistance or virulence genes. Additionally, use of this method may lead to identification of new 
vectors and increase understanding of the interaction among bacteria isolated from humans, 
animals, and the environment. 
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Table 1. CTX-M-14–producing Escherichia coli isolates used in this study* 
Origin Year Location Strain/plasmid Inc type Source 
Cattle 2004 England/Wales C159/11/ pCT K  (15,16) 
Cattle 2006 England/Wales I779 F, K NRL 
Cattle 2008 England/Wales I780 F, K NRL 
Cattle 2008 England/Wales I781 FIA NRL 
Cattle 2009 England/Wales I782 F NRL 
Cattle 2007 England/Wales I783 Unknown NRL 
Cattle 2008 England/Wales I784 Unknown NRL 
Cattle 2008 England/Wales I785 Unknown NRL 
Cattle 2006 England/Wales I786 I1-γ NRL 
Cattle 2006 England/Wales I787 Unknown NRL 
Cattle 2008 England/Wales I788 Unknown NRL 
Cattle 2008 England/Wales I789 Unknown NRL 
Cattle 2006 England/Wales I790 Unknown NRL 
Cattle 2008 England/Wales I791 F NRL 
Cattle 2008 England/Wales I792 F NRL 
Cattle 2008 England/Wales I793 F NRL 
Human No data England L125 Unknown P. Hawkey, unpub. data
Human 2006 Germany 386 FII  (17) 
Human 2006 Germany 400 FII  (17) 
Human 2003–4 Spain C574 K  (18) 
Human 2003–4 Spain C559 K  (18) 
Human 2003–4 Spain C567 K  (18) 
Human 2001–5 Spain FEC383/ pRYC105 K  (11) 
Human 2002 Spain E36/ pRYC110 HI2  (11) 
Human 1998 People’s Republic of China CH13/ pOZ174 Unknown  (19) 
Human 2005–7 Australia JIE 052 B  (20) 
Human 2005–7 Australia JIE 081 FII  (20) 
Human 2005–7 Australia JIE 084 FII  (20) 
Human 2005–7 Australia JIE 088 I1  (20) 
Human 2005–7 Australia JIE 182 B  (20) 
Human 2005–7 Australia JIE 201 K  (20) 
*CTX-M, cefotaximase-modifying; NRL, National Reference Laboratory for Enteric Zoonotic Bacteria of Animal Origin of the Veterinary Laboratories 
Agency, New Haw, UK. 
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Table 2. Primers used for detecting pCT-like regions in plasmids from Escherichia coli, United Kingdom, Europe, Australia, and Asia, 
2006–2009 
Primer Sequence, 5′ → 3′ Target DNA sequence Size, bp pCT binding site Reference
CTX-M-G9 (F) ATGGTGACAAAGAGAGTGCAAC blaCTX-M group 9 variants 876 70259–70280 (25) 
CTX-M-G9 (R) TTACAGCCCTTCGGCGATG blaCTX-M group 9 variants 876 69405–69423 (25) 
ISEcp1A (F) GCAGGTCTTTTTCTGCTCC Insertion sequence ISEcp1 527 71728–71746 (27) 
ISEcp1B (R) ATTTCCGGAGCACCGTTTGC Insertion sequence ISEcp1 527/1,037† 71220–71239 (27) 
B3A (F) AACGGCACAATGACGCTGGC Insertion sequence IS903 887 69913–69932 (24) 
IS903 (R) TGTAATCCGGCAGCGTA Insertion sequence IS903 887 69045–69061 (24) 
Pseudo (R) AACATTCGGCCGTTCACAGC Region downstream of blaCTX-M-14 1,636 68644–68663 This study
traK (F) GGTACCGGCATCGCACAGAA Region upstream of ISEcp1 1,037 72238–72257 This study
Sigma (F) ACAGCGTCTTCTCGTATCCA pCT putative sigma factor 1,289 48590–48609 This study
Sigma (R) GTTCTTCCAGCTGACGTAAC pCT putative sigma factor 1,289 47320–47339 This study
pCT rci (F) AAGGTCATCTGCAGGAGT pCT shufflon recombinase 945 78364–78381 This study
pCT rci (R) GTGTGCGCAGCAACAATA pCT shufflon recombinase 945 77436–77453 This study
pilN (F) GACAGGCAGAGAACACCAGA pCT pilN outer membrane protein 627 88267–88286 This study
pilN (R) ATGCTGTTCCACCTGATGAG pCT pilN outer membrane protein 627 87659–87678 This study
nikB (F) CGTGCMTGCCGTGARCTT IncI complex nikB relaxase gene 290 33077–33094 This study
nikB (R) TCCCAGCCATCCWTCACC IncI complex nikB relaxase gene 290 33350–33367 This study
pCT008 (F) CATTGTATCTATCTTGTGGG pCT pCT008-pCT009 region 428 3665–3684 This study
pCT009 (R) GCATTCCAGAAGATGACGTT pCT pCT008-pCT009 region 428 4074–4093 This study
*pCT, IncK plasmid; CTX-M, cefotaximase-modifying; F, forward primer; R, reverse primer. 
†Primer ISEcp1B can be paired with primer ISEcp1A (527 bp) or with primer traK (1,037 bp). 
 
 
Figure 1. Circular map of plasmid pCT. Open reading frames are color coded as follows: brown, 
pseudogenes; orange, hypothetic proteins; light pink, insertion sequences; light blue, tra locus; green, pil 
locus; dark pink, antimicrobial drug resistance gene; yellow, putative sigma factor; red, replication-
associated genes. Arrows show the direction of transcription. pCT, IncK plasmid. 
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Figure 2. Artemis Comparison Tool (Sanger, Cambridge, UK) comparisons of IncK plasmid (pCT) with 
other plasmids. Complete DNA sequence plasmid comparisons. Bands of color indicate homology 
between sequences. Red lines show sequence in the same confirmation; blue lines indicate sequence 
inversion. The pCT sequence is represented as the top line of each comparison compared with pO26_vir 
(GenBank accession no. FJ38659) (A); R387 (B); R64 (accession no. AP005147) (C); and pEK204 
(accession no. EU935740) (D) on each bottom line. 
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Figure 3. Phylogenetic analysis of nikB in IncI complex plasmids from Escherichia coli. DNA sequences of 
nikB PCR amplicons and sequences obtained from public resources were aligned and analyzed by using 
MEGA 4.0 (19). A neighbor-joining tree was constructed by using complete deletion modeling and 
computed by using the maximum composite likelihood method (30). The phylogenetic tree was linearized 
assuming equal evolutionary rates in all lineages. Circles, nikB sequences from plasmids isolated from 
veterinary isolates from the United Kingdom; triangles, nikB sequences of plasmids from Escherichia coli 
isolated from humans; squares, nikB sequences of plasmids obtained from GenBank or the Sanger 
Institute; shaded shapes, plasmids identified as pCT-like by using PCR in this study; asterisks, plasmids 
encoding blaCTX-M-14. pCT, IncK plasmid. Scale bar indicates nucleotide substitutions per site. 
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